Ling Liang

Dr. Ling Liang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CLChuang Li
Chuang Li
LCLifeng Chen
Lifeng Chen
ZLZhihao Li
Zhihao Li
LLLing Liang
Ling Liang
BLBenyong Lou
Benyong Lou
Adenosine (ADO), as an endogenous purine nucleoside, can regulate almost all aspects of tissue function. However, its abnormal accumulation in the tumor microenvironment (TME) induces immune tolerance and promotes tumor immune evasion by activating adenosine receptors (ADOR). Regulating ADO metabolism in the TME holds promise for ameliorating ADO-mediated immunosuppression and restoring antitumor immune responses. Extensive research has highlighted the pivotal role of ADO in tumor immune suppression and preclinical development of inhibitors targeting ADOR. However, systematic integration in ADO metabolism of microenvironmental influences, enzyme and protein regulation, and targeted intervention strategies through multiple pathways remain insufficient. This review systematically summarizes the key aspects of targeting ADO-mediated immunosuppression, including the feature of TME, enzymes involved in ADO metabolism (e.g., CD39/CD73/ADK/ADA), and ADOR interventions. Additionally, the necessity of comprehensively regulating ADO metabolism and the immune microenvironment through multi-level coordinated interventions is also explored, as well as the latest combined regulatory strategies. Moreover, the major challenges in current research on ADO metabolic regulation are also critically analyzed and the future research directions are proposed to address the dual challenges of ADO metabolic diversity and TME complexity, aiming to develop more precise and effective immunotherapeutic strategies.

Verified
Journal Article
Open access
PDF file
MZMei Zhang
Mei Zhang
LZLinjie Zheng
Linjie Zheng
BLBenyong Lou
Benyong Lou
YZYanjie Zhang
Yanjie Zhang
RSRongjian Sa
Rongjian Sa
LZLongtao Zhang
Longtao Zhang
Bioactive polysaccharides (e.g., fucoidan, β-glucans, and medicinal plant polysaccharides) contain functional groups that interact with drug molecules, and some also retain their own biological activities. Through reversible noncovalent interactions, they can associate with small-molecule drugs and form supramolecular nanocomplexes, defined here as nanoscale assemblies in which the polysaccharide is a main structural component and its association with the drug contributes to assembly or drug retention. Multicomponent composites and bulk local matrices are discussed separately as related or extended systems. The review covers hydrogen bonding, hydrophobic association, electrostatic complexation, π–π stacking, and the cooperation among these interactions, together with the effects of pH, ionic strength, concentration, and solvent composition. Nanoprecipitation/solvent exchange, polyelectrolyte complexation, direct aqueous self-assembly, and microfluidic-assisted assembly are compared with respect to nanostructure formation, process control, and reproducibility. Molecular, colloidal, solid-state, and computational evidence is examined together when interpreting structure–assembly–performance relationships. Reported advantages include improved drug dispersibility, colloidal stability, release control, bioavailability, cellular uptake, biodistribution, and safety. In some systems, the polysaccharide itself may also contribute to therapeutic effects in tumors, inflammatory diseases, and wound healing. Related local-matrix systems are considered separately. Further development of these nanocomplexes will require better quantitative analysis of assembly mechanisms, more consistent polysaccharide characterization, careful biocompatibility assessment, scalable preparation, and longer-term safety evaluation.

20 December 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YZYanjie Zhang
Yanjie Zhang
QGQuanhu Guo
Quanhu Guo
LLLing Liang
Ling Liang
ZMZhang Mei
Zhang Mei
RSRongjian Sa
Rongjian Sa
BLBenyong Lou
Benyong Lou
Background/Objectives: The poor aqueous solubility of curcumin (CUR) limits its pharmaceutical application. Although amorphization can enhance its solubility, the amorphous form often exhibits insufficient physical stability. Co-amorphization, particularly drug–drug co-amorphous (CAM) formation, offers a promising approach to improve solubility, stability, and therapeutic efficacy. This study aimed to prepare and evaluate two CUR-based CAM systems using isoquinoline alkaloids berberine hydrochloride (BER) and palmatine hydrochloride (PAL) as co-formers to achieve simultaneous stabilization and synergistic bioactivity. Methods: CUR-BER and CUR-PAL CAM systems were prepared via rotary evaporation under vacuum at a 1:1 molar ratio. The solid-state properties were characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), scanning electron microscope (SEM), and 13C solid-state nuclear magnetic resonance spectroscopy (ssNMR). Dissolution, solubility, and stability studies were conducted, while antioxidant and anticancer activities were assessed by DPPH/ABTS+ radical-scavenging and MTT assays using HT-29 colorectal cancer cells. Results: PXRD and DSC confirmed the formation of single-phase amorphous systems with higher glass transition temperatures, indicating strong intermolecular interactions between CUR and BER/PAL. 13C ssNMR spectroscopy evidenced hydrogen-bond formation between the enolic hydroxyl moiety of CUR and the methoxy oxygen atoms in BER or PAL molecules. Both CAM systems significantly enhanced the solubility and dissolution rate of CUR, with CUR-PAL CAM showing up to a 15.1-fold solubility improvement. The CAM systems also displayed superior thermal stability, photolytic stability, and improved short-term humidity resistance, together with enhanced antioxidant and anticancer activities compared with pure amorphous CUR. Conclusions: Co-amorphization of CUR with isoquinoline alkaloids effectively improved solubility, stability, antioxidant and anticancer activities, representing a promising strategy for the rational design of multifunctional amorphous CUR-based drug formulations.

18 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YZYanjie Zhang
Yanjie Zhang
QGQuanhu Guo
Quanhu Guo
LLLing Liang
Ling Liang
ZMZhang Mei
Zhang Mei
RSRongjian Sa
Rongjian Sa
BLBenyong Lou
Benyong Lou

Background/Objectives: The poor aqueous solubility of curcumin limits its pharmaceutical application. Although amorphization can enhance its solubility, the amorphous form often exhibits insufficient physical stability. Co-amorphization, particularly drug-drug co-amorphous (CAM) formation, offers a promising approach to improve solubility, stability, and therapeutic efficacy. This study aimed to prepare and evaluate two CUR-based CAM systems using isoquinoline alkaloids berberine chloride (BER) and palmatine chloride (PAL) as co-formers to achieve simultaneous stabilization and synergistic bioactivity. Methods: CUR-BER and CUR-PAL CAM systems were prepared via rotary evaporation under vacuum at a 1:1 molar ratio. The solid-state properties were characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and solid-state ¹³C NMR spectroscopy. Dissolution, solubility, and stability studies were conducted, while antioxidant and anticancer activities were assessed by DPPH/ABTS⁺ radical-scavenging and MTT assays using HT-29 colorectal cancer cells. Results: PXRD and DSC confirmed the formation of single-phase amorphous systems with higher glass transition temperatures, indicating strong intermolecular interactions between CUR and BER/PAL. 13C ssNMR spectroscopy evidenced hydrogen-bond formation between the enolic hydroxyl moiety of CUR and the methoxy oxygen atoms in BER or PAL molecules. Both CAM systems significantly enhanced the solubility and dissolution rate of CUR, with CUR-PAL CAM showing up to a 15.1-fold solubility improvement. The CAM systems also displayed excellent physical stability and synergistic antioxidant and anticancer effects compared with pure amorphous CUR. Conclusions: Co-amorphization of CUR with isoquinoline alkaloids effectively improved solubility, stability, and pharmacological synergy, representing a promising strategy for the rational design of multifunctional amorphous drug formulations for combinatorial cancer therapy.


4 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MZMei Zhang
Mei Zhang
LZLinjie Zheng
Linjie Zheng
BLBenyong Lou
Benyong Lou
YZYanjie Zhang
Yanjie Zhang
RSRongjian Sa
Rongjian Sa
LZLongtao Zhang
Longtao Zhang
Bioactive polysaccharides such as fucoidan, β-glucans, and medicinal plant polysaccharides contain functional groups that can interact with drug molecules, and some of them also retain their own biological activities. Through reversible noncovalent interactions, these polysaccharides can associate with small-molecule drugs and form supramolecular nanocomplexes. This review discusses hydrogen bonding, hydrophobic association, electrostatic complexation, π–π stacking, and the cooperation among these interactions. The effects of pH, ionic strength, concentration, and solvent composition on assembly behavior are also considered. Nanoprecipitation/solvent exchange, polyelectrolyte complexation, direct aqueous self-assembly, and microfluidic-assisted assembly are compared in terms of nanostructure formation, process control, and reproducibility. Evidence from molecular, colloidal, solid-state, and computational characterization is considered together to clarify the relationship between structure, assembly, and performance. Reported benefits include improved drug dispersibility, colloidal stability, release control, bioavailability, cellular uptake, biodistribution, and safety. In some systems, the polysaccharide component may also contribute to therapeutic effects in tumors, inflammatory diseases, infected wounds, and local regenerative matrices. Quantitative mechanism studies, polysaccharide standardization, biocompatibility assessment, process scale-up, and long-term safety evaluation remain necessary for the further development of these drug delivery systems.